首页> 外国专利> Novel enantioenriched bisindolylmethane sulfamate derivatives and the compositions for treating neuropathy comprising thereof

Novel enantioenriched bisindolylmethane sulfamate derivatives and the compositions for treating neuropathy comprising thereof

机译:新型对丙烯醛脱嘌呤基甲烷磺酸衍生物及其治疗其含神经病变的组合物

摘要

The present invention relates to a compound represented by Formula 1 or a pharmaceutically acceptable salt thereof; a method for preparing the compound; And it relates to a pharmaceutical composition for preventing or treating diabetic neuropathy comprising the compound or a pharmaceutically acceptable salt thereof as an active ingredient. The novel optically active bisindorylmethane sulfamate derivative compound of the present invention acts on semi-cells to inhibit the neuroaxon degeneration of Schwann cells and dedifferentiation of Schwann cells, thereby preventing the degeneration of peripheral nerves and effectively preventing or preventing diabetic neuropathy. could be used for treatment. In addition, the method for preparing the compound according to the present invention enables eco-friendly production at a lower cost compared to the case of using a conventional metal catalyst by using an optically active organic catalyst.
机译:本发明涉及由式1表示的化合物或其药学上可接受的盐; 一种制备化合物的方法; 并且它涉及用于预防或治疗糖尿病神经病变的药物组合物,其包含化合物或其药学上可接受的盐作为活性成分。 本发明的新型光学活性Bisindorylmethane磺酸酯衍生物化合物作用于半细胞,以抑制施万细胞的神经舒森退化和施万细胞的去除湿,从而防止周围神经的退化,有效预防或预防糖尿病神经病变。 可用于治疗。 另外,与使用光学活性的有机催化剂使用常规金属催化剂的情况相比,制备根据本发明的化合物的制备方法使得能够以较低的成本。

著录项

  • 公开/公告号KR102349523B1

    专利类型

  • 公开/公告日2022-01-07

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR1020200012651

  • 发明设计人 김성곤;

    申请日2020-02-03

  • 分类号C07D403/06;A61K31/404;A61P25;

  • 国家 KR

  • 入库时间 2022-08-24 23:26:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号